Caribbean HCP Research: Methodology Guide for Pharma 2026

Caribbean healthcare professional (HCP) research methodology combines specialist recruitment from small but accessible physician populations across the region, country-specific compliance with pharmaceutical industry standards including ABPI, PhRMA, and IFPMA frameworks, and methodology choices adapted to local practice patterns. The most common formats include in-depth interviews with eight to fifteen specialists per country, quantitative HCP surveys deployed via CAPI or CATI, advisory boards convening five to eight regional key opinion leaders, and mixed-method patient journey mapping. Effective programs design around specialist availability rather than imposing fieldwork timing, deliver honoraria consistent with country standards, and maintain rigorous confidentiality given how small Caribbean specialist communities are.

Why HCP Research in the Caribbean Is Different

HCP research conducted in the Caribbean follows the same fundamental methodological principles as research in larger pharmaceutical markets, but operational execution diverges in ways that determine whether a program succeeds or quietly produces unusable data. Four structural realities define Caribbean HCP fieldwork.

The specialist universe is finite and easily exhausted. Jamaica has approximately 4,500 registered physicians of all specialties, Trinidad and Tobago has roughly 2,200, Barbados has approximately 600, and the OECS islands collectively count fewer than 1,500. Subspecialist populations are correspondingly small: Jamaica has roughly 50 medical oncologists, fewer than 100 cardiologists, and similar counts of endocrinologists and pulmonologists. A research program needing 15 oncologist interviews across the English-speaking Caribbean has already drawn from 30 percent of the available regional specialist pool. Programs designed without an understanding of these denominators routinely fail at recruitment.

Specialists are over-approached by competing research firms. Because specialist populations are small, the most accessible Caribbean physicians are frequently contacted by global market research agencies running similar studies. Diabetologists in Kingston, oncologists in Port of Spain, and cardiologists in Santo Domingo are the most common targets. Programs that approach physicians cold without warm introductions or existing relationships face higher refusal rates than the same study would in larger markets.

Compliance frameworks vary by sponsor and by country. Global pharmaceutical sponsors require HCP research to comply with their corporate standards, which typically align with ABPI in the United Kingdom, PhRMA in the United States, IFPMA at the international level, and local pharmaceutical industry association codes where they exist. Honoraria documentation, transfer-of-value reporting under the US Physician Payments Sunshine Act, and country-specific advertising and inducement rules all apply. Programs that miss these requirements produce data that sponsors cannot use.

English-speaking and Spanish-speaking Caribbean operate as different research markets. Jamaica, Trinidad, Barbados, Bahamas, and the English-speaking OECS use English in clinical and research contexts. The Dominican Republic operates entirely in Spanish. Puerto Rico is bilingual with US-aligned regulatory expectations. Programs covering the broader Caribbean need either bilingual operational capability or careful country segmentation in design.

The Caribbean HCP Universe by Country

Methodologies for Caribbean HCP Research

Five core methodologies cover most pharmaceutical sponsor needs. Selection depends on the research question, available specialist counts, and depth of insight required.

In-Depth Interviews (IDIs)

The workhorse method for therapeutic area research, treatment pathway exploration, competitive intelligence, and unmet need identification. Caribbean IDI programs typically interview 8-15 specialists per country in cardiology, endocrinology, oncology, neurology, pulmonology, or other focus areas. Standard length runs 45-60 minutes for specialists and 30-45 minutes for general practitioners. Caribbean IDIs are typically conducted by experienced moderators with clinical or pharmaceutical research background. Telephone or video conferencing increasingly replaces face-to-face given physician time constraints, though face-to-face remains preferred for advisory board work and longer engagements.

Quantitative HCP Surveys

Used for market sizing, segmentation, treatment-flow mapping, and tracking studies. Caribbean HCP quantitative work deploys via three primary channels:

CAPI (computer-assisted personal interviewing) in physician offices remains the gold standard for response quality and physician engagement. A trained interviewer visits the physician and completes the structured interview on a laptop or tablet. CAPI works well in Caribbean markets where physician offices are geographically concentrated.

CATI (computer-assisted telephone interviewing) suits time-pressed specialists. CATI runs higher refusal rates than CAPI in the Caribbean but achieves reasonable participation when scheduled around physician availability. Online HCP panel works best in Puerto Rico, with younger Caribbean specialist cohorts, and with US-trained specialists across the region. Typical sample sizes run 200-300 physicians for single-country surveys, 400-600 for multi-country regional surveys.

Advisory Boards

Five to eight regional key opinion leaders convene for half-day or full-day structured discussions on emerging therapies, treatment guidelines, unmet needs, or competitive landscape. Advisory boards typically include senior specialists from major academic medical centers (UWI, EWMSC, Mt Hope, Hospital Plaza de la Salud, Centro Médico Puerto Rico) plus established private practitioners. Caribbean advisory boards work best when convened in person at central locations (Kingston, Port of Spain, Santo Domingo, Miami) rather than entirely virtual.

Online HCP Communities

Asynchronous discussion forums where 15-30 physicians participate over 1-3 weeks. Useful for longitudinal insight, concept testing iterations, and competitive intelligence gathering. Caribbean online community work is growing as digital adoption increases but still represents a minority of total HCP research effort.

Mixed-Method Patient Journey Mapping

Combines HCP qualitative input with patient interviews and quantitative validation to build country-specific care pathways from symptom onset through diagnosis, treatment selection, adherence, and outcomes monitoring. This is the most insight-dense methodology and the most operationally demanding. See also: Caribbean Patient Recruitment Methodology.

Recruitment Channels for Caribbean HCPs

Effective HCP recruitment requires multiple channels working in parallel. No single channel reliably delivers Caribbean specialists at the volumes most pharmaceutical research needs.

• Maintained HCP databases with continuous refresh form the recruitment foundation. Hope Research Group maintains country-by-country physician databases segmented by specialty, practice setting (academic, private, public), age cohort, and prior research participation history.
• Academic medical center networks anchor most Caribbean specialist recruitment. UWI hospitals in Jamaica, Trinidad, and Barbados, the Mt Hope Medical Sciences Complex, EWMSC, Centro Médico in Puerto Rico, and similar institutions concentrate teaching hospital specialists who participate in research more readily than community practitioners.
• Specialist society networks support targeted recruitment in cardiology, oncology, endocrinology, dermatology, and other specialty areas where regional societies coordinate professional activity.
• Hospital department heads can facilitate recruitment within their institutions for studies that align with departmental interests.
• Snowball recruitment from existing relationships uses already-participating physicians to identify and warm-introduce additional specialists. Most effective in small specialty pools where physicians know one another well.
• Diaspora networks support Caribbean specialist research conducted from US, Canada, or UK collection points. Caribbean-trained physicians practicing abroad often retain regional perspective and can supplement in-market samples.

Honoraria Standards Across the Caribbean

Honoraria for Caribbean HCP research follow industry norms with country-specific adjustments. The ranges below reflect typical 2026 standards and must be processed in compliance with sponsor frameworks including ABPI, PhRMA, and IFPMA. Honoraria payments should never be conditioned on specific research conclusions and must be documented through compliant payment processing that produces audit-ready records.

Compliance Frameworks That Apply

Three layers of compliance affect Caribbean HCP research design and execution.

Sponsor-level pharmaceutical industry standards. Most global pharmaceutical sponsors require their research suppliers to operate under defined codes including ABPI (UK), PhRMA (US), IFPMA (international), and regional industry associations. These frameworks govern honoraria, transparency, and the line between research and promotion.

Country-specific regulatory requirements. Pharmaceutical advertising and inducement rules apply differently across Caribbean markets. Jamaica's Ministry of Health regulates promotional activity through the Pharmaceutical and Therapeutic Services Division. The Dominican Republic uses DIGEMAPS for pharmaceutical regulation. Puerto Rico follows US FDA frameworks. Research that crosses into promotional or educational territory requires careful design to stay within regulatory boundaries.

Institutional ethics review. Research that involves protected health information, clinical data abstraction, or any patient-level component typically requires ethics committee approval. Pure HCP perception research generally does not require formal IRB approval but should still follow informed consent and confidentiality protocols. See also: Caribbean Pharma Fieldwork: 2026 Complete Guide.

Sample Design Considerations Specific to the Caribbean

Smaller absolute sample sizes are usually defensible. A program studying treatment paradigms in Jamaica reasonably samples 12-15 specialists per therapeutic area. Specialist populations are small enough that 15 well-recruited physicians can represent 30 percent of the available pool.

Multi-country sampling requires careful stratification. Pan-Caribbean studies that pool Jamaica, Trinidad, DR, Puerto Rico, and Barbados into a single sample lose country-specific signal. Most useful designs stratify by country with reporting at both country and regional level.

Practice setting matters. Academic specialists, private practitioners, and public hospital physicians may make different prescribing decisions in the same Caribbean market. Sample design should consider whether to stratify by practice setting. Language stratification is essential for pan-Caribbean programs covering both English-speaking and Spanish-speaking markets.

Common Methodological Errors

• Designing for sample sizes that exceed available specialists. A program requiring 25 oncologist IDIs across the English-speaking Caribbean is operationally impossible.
• Using a single language instrument for the entire region. English-only instruments deployed in the Dominican Republic produce low-quality data.
• Importing US or European honoraria scales without adjustment. Over-payment raises sponsor compliance concerns. Under-payment fails recruitment.
• Ignoring practice setting differences. Treating all Caribbean specialists as interchangeable misses important treatment-decision variation.
• Approaching cold without warm introduction. Caribbean specialist networks are tight. Recruiters who lack existing relationships face refusal rates that compromise sample quality.
• Skipping quality control on submitted reports. Programs that accept everything submitted produce data sponsors will reject.
• Conducting research in time windows that conflict with clinical commitments. Programs that ignore physician schedules accumulate cancellations that delay timelines.

Costs by Methodology

How to Choose an HCP Research Vendor in the Caribbean

The vendor selection markers that reliably distinguish capable firms from generalist research companies focus on operational capability rather than presentation polish. Ask for:

• Years of HCP-specific research history in the Caribbean with documented therapeutic area experience
• HCP database size and refresh cadence by country and specialty
• Specific specialist counts the firm has interviewed in your therapeutic area in the past 24 months
• Honoraria management documentation and pharmaceutical industry compliance certification
• Two or three pharmaceutical sponsor references willing to discuss program execution
• Sample reports from comparable Caribbean HCP programs (de-identified)
• Bilingual operational capability demonstrated through completed programs, not claimed competency
• Specific recruiters and moderators who would work on your program

Vendors that respond with general capability statements rather than specific examples should be approached with caution.

Frequently Asked Questions

Related Hope Research Group Resources

• Healthcare and Pharmaceutical Market Research
• Caribbean Pharma Fieldwork: 2026 Complete Guide
• Caribbean Patient Recruitment Methodology
• Jamaica Market Research Overview
• Dominican Republic Market Research
• How to Conduct Market Research in Jamaica